CASI PHARMACEUTICALS, INC. Defined Contribution Plan, Cost
CASI PHARMACEUTICALS, INC. (CASIF) reported Defined Contribution Plan, Cost of $3.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-05-15
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2025-12-31 | $3.00M 20-F · filed 2026-05-15 |
| 2024-12-31 | $4.20M 20-F · filed 2026-05-15 |
| 2023-12-31 | $4.30M 20-F · filed 2026-05-15 |
| 2022-12-31 | $4.20M 20-F · filed 2025-03-31 |
| 2021-12-31 | $3.10M 20-F · filed 2024-03-28 |
| 2020-12-31 | $1.50M 20-F · filed 2023-04-26 |